Shai Shimony[Author] - Search Results

Year	Number of Results
2019	5
2020	4
2021	6
2022	12
2023	15
2024	9

1

Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management.

Shimony S, Stahl M, Stone RM. Shimony S, et al. Am J Hematol. 2023 Mar;98(3):502-526. doi: 10.1002/ajh.26822. Epub 2023 Jan 13. Am J Hematol. 2023. PMID: 36594187 Free article. Review.

2

Epidemiology and Pathogenesis of Myelodysplastic Syndrome.

Rotter LK, Shimony S, Ling K, Chen E, Shallis RM, Zeidan AM, Stahl M. Rotter LK, et al. Among authors: shimony s. Cancer J. 2023 May-Jun 01;29(3):111-121. doi: 10.1097/PPO.0000000000000665. Cancer J. 2023. PMID: 37195766 Review.

3

Unraveling KMT2A-rearranged ALL.

Shimony S, Luskin MR. Shimony S, et al. Blood. 2023 Nov 23;142(21):1764-1766. doi: 10.1182/blood.2023021942. Blood. 2023. PMID: 37995105 No abstract available.

4

Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia.

Shimony S, DeAngelo DJ, Luskin MR. Shimony S, et al. Blood Adv. 2024 Jan 9;8(1):23-36. doi: 10.1182/bloodadvances.2023010303. Blood Adv. 2024. PMID: 37389830 Free PMC article. Review.

5

Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS.

Frumm SM, Shimony S, Stone RM, DeAngelo DJ, Bewersdorf JP, Zeidan AM, Stahl M. Frumm SM, et al. Among authors: shimony s. Blood Rev. 2023 Jul;60:101056. doi: 10.1016/j.blre.2023.101056. Epub 2023 Feb 12. Blood Rev. 2023. PMID: 36805300 Review.

6

Untangling Complexities of Acute Myeloid Leukemia Review Series.

Shimony S, Stone RM. Shimony S, et al. Acta Haematol. 2024;147(2):119-121. doi: 10.1159/000535574. Epub 2023 Nov 30. Acta Haematol. 2024. PMID: 38035554 No abstract available.

7

Hypomethylating agents plus venetoclax compared with intensive induction chemotherapy regimens in molecularly defined secondary AML.

Shimony S, Bewersdorf JP, Shallis RM, Liu Y, Schaefer EJ, Zeidan AM, Goldberg AD, Stein EM, Marcucci G, Lindsley RC, Chen EC, Ramos Perez J, Stein A, DeAngelo DJ, Neuberg DS, Stone RM, Ball B, Stahl M. Shimony S, et al. Leukemia. 2024 Apr;38(4):762-768. doi: 10.1038/s41375-024-02175-0. Epub 2024 Feb 20. Leukemia. 2024. PMID: 38378841

8

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years.

Shimony S, Fell G, Chen EC, Tsai HK, Wadleigh M, Winer ES, Garcia JS, Luskin MR, Stahl M, Neuberg DS, DeAngelo DJ, Lindsley RC, Stone RM. Shimony S, et al. Blood Adv. 2023 Sep 26;7(18):5354-5358. doi: 10.1182/bloodadvances.2023009748. Blood Adv. 2023. PMID: 37163357 Free PMC article.

9

Tri-ing to decipher trisomy AML.

Shimony S, Chen EC. Shimony S, et al. Br J Haematol. 2024 Mar;204(3):751-752. doi: 10.1111/bjh.19294. Epub 2024 Jan 8. Br J Haematol. 2024. PMID: 38190804

10

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia.

Shimony S, Liu Y, Valtis YK, Paolino JD, Place AE, Brunner AM, Weeks LD, Silverman LB, Vrooman LM, Neuberg DS, Stone RM, DeAngelo DJ, Luskin MR. Shimony S, et al. Blood Adv. 2023 Apr 11;7(7):1092-1102. doi: 10.1182/bloodadvances.2022008280. Blood Adv. 2023. PMID: 36508268 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

44 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year